Soluble ST2 in end‐stage heart failure, before and after support with a left ventricular assist device

BACKGROUND: The interleukin‐33 (IL‐33)/suppressor of tumorigenicity 2 (ST2) pathway is suggested to play an important role in fibrosis, remodelling and the progression of heart failure (HF). Increased soluble (sST2) levels are associated with adverse outcome in the average HF population. Less is kno...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur J Clin Invest
Asıl Yazarlar: Tseng, Cheyenne C. S., Huibers, Manon M. H., Gaykema, Lonneke H., Siera‐de Koning, Erica, Ramjankhan, Faiz Z., Maisel, Alan S., de Jonge, Nicolaas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5838535/
https://ncbi.nlm.nih.gov/pubmed/29325227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/eci.12886
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller